title: Radiation and immunotherapy: Renewed allies in the war on cancer.
abstract: Anticancer immunotherapy holds great promises, as long-term responses to interleukin-2 have been observed in metastatic melanoma and renal cell carcinoma patients. However, improving the relative low rates of such responses has constituted a great challenge. In our experience, high-dose radiation combined with interleukin-2 provided encouraging results that are worth exploring further.
authors.affiliation: Earle A. Chiles Research Institute; Portland, OR USA ; The Oregon Clinic; Portland, OR, USA ; Providence Cancer Center; Portland, OR USA.
authors.forename: Steven K
authors.initials: SK
authors.lastname: Seung
authors.forename: Brendan
authors.initials: B
authors.lastname: Curti
authors.forename: Marka
authors.initials: M
authors.lastname: Crittenden
authors.forename: Walter
authors.initials: W
authors.lastname: Urba